When they are placed in a low-oxygen environment, Rejuvenare’s stem cells transform to become more vascular in orientation, and they also release various growth factors, which significantly aid in the healing process.
Once the processed stem cells are implanted directly to the heart using a catheter through the carotid artery via Rejuvenare’s proprietary delivery protocols,
As mentioned before, the above treatments offered my mainstream medicine today only serve often as a temporary solution to the problem, and, once patients have exhausted those alternatives, they become labeled as “no-option heart patients”. This means that there is nothing medicine can do to help them in their current state, as some patients may not be qualified to undergo heart transplantation, while others might not be matched with a donor in time.
In the past, exhaustion of these traditional cardiac treatment options meant being labeled as a “no-option” heart patient. Further, some patients may be unable to undergo heart transplantation while others may not be matched with a donor heart in time. Despite the use of current available treatments, these “no-option” patients experience deterioration in their quality of life, and their life expectancy shortens.
Rejuvenare therapy utilizes stem cells obtained from the patient’s own bone marrow. These cells are placed back directly into the patient’s heart via a catheter using Rejuvenare’s proprietary delivery protocols, where they prompt the growth of new blood vessels. This non-invasive procedure can restore normal blood flow to the heart thus greatly improving heart function.
Rejuvenare has had great results with many documented cases for heart procedures utilizing processed stem cells delivered by our proprietary protocols, bringing new hope for coronary artery disease patients.